The team applied this method to mRNA/saRNA constructs from 1 to 10 kb and assessed pH ranges from 3 to 6. For all the RNA constructs, the J2 immunoblot signal—a marker for dsRNA strands—decreased with ...

COVID-19 vaccine stock Moderna just got its biggest lift in recent memory, moving up 17%. Can MRNA stage a broader recovery, ...

Despite Sanofi CEO Paul Hudson’s confidence in vaccines, the French pharma has cut at least one mRNA flu shot program.

A combination of intismeran autogene and Keytruda significantly prolonged recurrence-free survival in melanoma.

A new study shows lipid nanoparticles can be formulated at much higher lipid concentrations using a modular mixing approach, ...

Dario Amodei, CEO of Anthropic, says more democracy is the best response to AI. He doesn’t sound too confident.

Investor attention around CureVac (NasdaqGM:CVAC) has picked up after management outlined incremental progress in its second generation mRNA vaccine programs with GSK, along with a more focused ...

Moderna, Inc. vs. Novavax, Inc.: cost cuts, vaccine pipeline catalysts, and valuations. Click for this comparison of NVAX and ...

The global vaccine Contract Development and Manufacturing Organization (CDMO) market is projected to expand at a compound ...

By adding AI-enabled RNA design and active learning, Eclipsebio extends its sequencing-based analytics platform into a fully ...

GENE202 is a single dose gene therapy for patients with rare metabolic disease, methylmalonic acidaemia.

Key market opportunities in the RNA Therapy Clinical Trials sector include an increase in chronic and rare diseases, advancements in delivery technologies like lipid nanoparticles, robust venture ...